tiprankstipranks
Trending News
More News >
Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN
US Market

Tevogen Bio Holdings (TVGN) Financial Statements

Compare
322 Followers

Tevogen Bio Holdings Financial Overview

Tevogen Bio Holdings's market cap is currently $63.16M. The company's EPS TTM is $-0.03; its P/E ratio is -1.78; Tevogen Bio Holdings is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -403.58K$ -378.36K$ 0.00$ 0.00
Operating Income$ -53.56M$ -8.84M$ -953.08K$ -4.62M
EBITDA$ -13.14M$ -58.89M$ 4.41M$ -14.99M
Net Income$ -10.11M$ -60.48M$ 4.41M$ -15.60M
Balance Sheet
Cash & Short-Term Investments$ 1.28M$ 1.05M$ 5.48M$ 7.12M
Total Assets$ 3.46M$ 5.51M$ 7.74M$ 7.66M
Total Debt$ 2.89M$ 95.42M$ 40.01M$ 23.48M
Net Debt$ 1.60M$ 94.37M$ 34.52M$ 16.36M
Total Liabilities$ 10.14M$ 99.93M$ 41.69M$ 24.15M
Stockholders' Equity$ -6.67M$ -94.43M$ -33.95M$ -16.49M
Cash Flow
Free Cash Flow$ -12.00M$ -8.30M$ -9.13M$ -5.38M
Operating Cash Flow$ -12.00M$ -8.17M$ -8.66M$ -5.27M
Investing Cash Flow$ 0.00$ -133.00K$ -479.04K$ -109.73K
Financing Cash Flow$ 12.23M$ 3.87M$ 7.50M$ 12.50M
Currency in USD

Tevogen Bio Holdings Earnings and Revenue History

Tevogen Bio Holdings Debt to Assets

Tevogen Bio Holdings Cash Flow

Tevogen Bio Holdings Forecast EPS vs Actual EPS